GlassScriptPhysician profile
Nicholas Dutcheshen
NPI 1568420305
$3,506.86
in general payments reported to CMS, 2019-2025
21 companies · $498 in 2025
The $498 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,060 · 2020: $483 · 2021: $328 · 2022: $138 · 2023: $849 · 2024: $152 · 2025: $498.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,149 · Travel and Lodging: $349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,149.32 |
| Travel and Lodging | $348.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,399.79 | 2019-2025 | N/A, Lens 4k, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Zimmer Biomet Holdings, INC. | $886.14 | 2019-2025 | Comprehensive Shoulder System, Choice Instruments |
| Pinnacle, INC | $211.78 | 2019-2021 | |
| Stryker Corporation | $147.52 | 2019 | |
| Depuy Synthes Sales INC. | $144.66 | 2023-2025 | Va-Lcp, Monovisc, Orthovisc |
| Vericel Corporation | $143.24 | 2019 | |
| Pacira Therapeutics, INC. | $121.68 | 2019 | |
| Medacta USA, INC. | $104.40 | 2023 | Reverse Shoulder |
| Wright Medical Technology, INC. | $95.42 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $36.69 | 2025 | Iovera, Exparel, Zilretta |
| Sanofi-Aventis U.S. LLC | $30.72 | 2019-2022 | |
| Solventum Corporation | $22.77 | 2025 | Prevena |
| Arthrex, INC. | $22.50 | 2024 | |
| Cerapedics INC. | $21.34 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Kuros Biosciences USA, INC | $20.02 | 2024 | Magnetos |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $19.14 | 2019 | |
| Linvatec Corporation | $18.34 | 2025 | Biobrace 23mm |
| Biocomposites INC | $18.03 | 2019 | |
| Radius Health, INC. | $15.82 | 2024 | Tymlos |
| Medtronic, INC. | $14.11 | 2023 | Aquamantys(Tm) |
| Endo Pharmaceuticals INC. | $12.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Dutcheshen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.